Features

Breast Cancer Genes: When the Sequence Is Not Enough

Few cancer genes are more notorious than the genes that cause familial breast cancer—BRCA1 and BRCA2. The New York Times described the cloning of BRCA1 in 1994 as "a genetic trophy so ferociously coveted and loudly heralded that it had taken on a near-mythic aura," but cautioned that since the gene was unexpectedly large, it might take at least a year before a diagnostic test could be developed from it. Read the full story »

Partners in Science:

The Umbrella CRADA Streamlines Collaborations Between CCR and Industry

Researchers across CCR are studying the molecular mechanisms that underlie multiple diseases. Read more about CCR's partners in science »

Nitric Oxide:

Just say NO to Cancer and Much More

Blood vessels use it to relax, neurons use it to communicate, and innate immune cells use it to kill dangerous invaders. Read more about nitric oxide (NO) »

Inflammation:

Where immune Cells and Blood Vessels Collide

In an average person, there are approximately 20,000,000,000 neutrophils patrolling the bloodstream on the lookout for trouble. Read more about immune cells »

News

Letting Sleeping Micrometastases Lie

A Cure for the Incurable?
Using the Body's Immune System to Treat Metastatic Cancers

alt text Big Things in Small Packages:

Small RNAs Play a Big Role in Cancer Biology

alt text Targeted Destruction:

Novel Interactions in Ubiquitylation and Tumorigenesis

alt text Recent CCR Awards:

View the new 2009 CCR awards

alt text Keeping Cell Suicide in Check:

Understanding how TRAIL activates apoptosis in cancer cells

alt text Brain Cancers:

Not All Made the Same

alt text In Conversation:

Research Fellow Aaron Schetter, Ph. D., M.P.H.

alt text Staff News at CCR

Staff announcements and new tenure-track scientists at CCR